@misc{indiciae9f4fc38df4d5,
  title = {The Clinical Response of Upadacitinib and Risankizumab is Associated with Reduced Inflammatory Bowel Disease Anti-TNFα Inadequate Response Mechanisms},
  author = {Wang, J. and Macoritto, M. and Guay, H. and Davis, J. W. and Levesque, M. C. and Cao, X.},
  year = {2022},
  doi = {10.1101/2022.05.16.492167},
  url = {https://www.biorxiv.org/content/10.1101/2022.05.16.492167v1},
  note = {Source identifier: 10.1101/2022.05.16.492167}
}